LUCENCE @ Virtual ASCO20May 29-31 , 2020
LUCENCE @ Virtual ASCO20May 29-31 , 2020

Join Lucence for Virtual ASCO, May 29th-31st.

Lucence is committed to advancing cancer care for the benefit of patients everywhere. We believe collaboration and partnership are now more important than ever and will be virtually participating in ASCO 2020, May 29th through May 31st, 2020.

Below you’ll find an overview of our upcoming news, a schedule of our virtual poster presentations and events (including a webinar on COVID-19 and lung cancer diagnosis, treatment, and monitoring), and an interface for booking a meeting with our leadership team.

We’re excited to share our work with you. Sign up here to make sure you receive the latest news and updates from us. For questions or assistance, do not hesitate to reach out to us at asco2020[at]lucence[dot]com.

Join Lucence for Virtual ASCO, May 29th-31st.

Lucence is committed to advancing cancer care for the benefit of patients everywhere. We believe collaboration and partnership are now more important than ever and will be virtually participating in ASCO 2020, May 29th through May 31st, 2020.

Below you’ll find an overview of our upcoming news, a schedule of our virtual poster presentations and events, and an interface for booking a meeting with our leadership team.

We’re excited to share our work with you. Sign up here to make sure you receive the latest news and updates from us. For questions or assistance, do not hesitate to reach out to us at asco2020[at]lucence[dot]com.

Join us for a special webinar on COVID-19 & Lung Cancer: Changing Care Worldwide

COVID-19 has impacted the diagnosis, treatment, and monitoring of lung cancer, worldwide. Learn more about how the coronavirus is affecting clinical presentation and care from experts in oncology and infectious disease.

Pre-Register for Webinar

NEWS

Lucence Shares Data Demonstrating High Sensitivity of AmpliMARK™ Sequencing Technology in Detecting Clinically Relevant Biomarkers in Lung Cancer

Coinciding with ASCO20, precision oncology company Lucence will be presenting data this week demonstrating high sensitivity of its liquid biopsy technology in detecting clinically relevant biomarkers in lung cancer, alongside promising data in breast and blood cancers. The data, presented as part of ASCO’s Virtual Scientific Program, show the Company’s AmpliMARK technology detection capability for recommended biomarkers with 97.4% concordance between two orthogonal liquid biopsy platforms in lung cancer. The Company is planning to make its LiquidHALLMARK test, powered by AmpliMARK, commercially available in the United States later this year for biomarker detection in lung cancer patients. Read more.

For press inquiries, please email [email protected]

Learn more about Lucence’s AmpliMARK amplicon-based sequencing technology here. Read more recent news from Lucence, including our work with COVID-19 here.

 


AGENDA, POSTER PRESENTATIONS & ABSTRACTS FOR ASCO 2020

Friday, May 29th, 2020
Virtual poster session from 8-11 am PT


Detection of actionable gene mutations in breast cancer by amplicon-based next-generation sequencing liquid biopsy.
Authors: Jing Shan Lim, Yukti Choudhury, Wai Min Phyo, Chaitanya Gupta, Yiliang Ho, Carina Tay, Yuki Sim, Wei Shuen Ng, Min-Han Tan, Janice Tsang and Hui Ti See
Abstract #1035
Poster number:120

Virtual poster session from 8-11 am PT


Ultrasensitive multiplex detection of structural rearrangements in ALK, RET, ROS1 and PD-L1 using a comprehensive next-generation sequencing assay
Authors: Kao Chin Ngeow, Yukti Choudhury, Daniel Tan, Michelle Pek, Kim-Tien Ng, Soon Thye Lim, Jing Quan Lim, Dachuan Huang, Choon Kiat Ong and Min-Han Tan
Abstract #3572
Poster #302

Abstracts

Clinical utility of a liquid biopsy diagnostic approach in lung cancer using amplicon-based next-generation sequencing in parallel with allele-specific PCR
Authors: Yukti Choudhury, Wai Min Phyo, Jing Shan Lim, Chaitanya Gupta, Yiliang Ho, Carina Tay, Yuki Sim, Wei Shuen Ng, Michelle Pek, Min-Han Tan, Tan Min Chin, Yew Oo Tan, Seng Weng Wong, Victor Hsue, William Foo, Wing Kin Sze, Siu Kei AU and Tai Chung Lam
Abstract #311045

An ultrasensitive amplicon-based sequencing panel for non-invasive molecular testing of hematological malignancies using blood
Authors: Chae Yin Cher, Zi Yi Lim, Daryl Tan, Hae Tha Mya, Wichean Mongkonsritragoon, Min-Han Tan and Yukti Choudhury
Abstract #308719

Thursday, June 4th, 2020
Webinar from 5-6 pm PT

Special Webinar: COVID-19 & Lung Cancer: Changing Care Worldwide

Pre-Register for Webinar


BOOK A MEETING

Book a meeting with our team seamlessly using the Calendly integration below or email a member of our team directly.

Min-Han Tan, MBBS, PhD, FAMSCEO & Medical Director[email protected]

Yukti Choudhury, PhDChief Technology Officer[email protected]

Jack Challis, PhDVP, US Operations[email protected]

Rita Melo-Nazareno, PharmD, PhDMedical Science Liaison[email protected]


GET UPDATES

Sign up for the latest news and updates about Lucence at ASCO 2020. For questions, email us at [email protected]



Need Help?